BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 34757 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NCC#N |r| InChI=1S/C23H26F3N3O3S/c1-15(2)14-20(22(30)28-13-12-27)29-21(23(24,25)26)18-6-4-16(5-7-18)17-8-10-19(11-9-17)33(3,31)32/h4-11,15,20-21,29H,13-14H2,1-3H3,(H,28,30) VYFDSJLOCIGIKP-UHFFFAOYSA-N 19489 (2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfon::(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::CHEMBL437501::L-873724 Cathepsin S Homo sapiens 178 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19489&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 9913088 46519505 CHEMBL437501 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34758 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C25H28F3N3O3S/c1-16(2)14-21(23(32)31-24(15-29)12-13-24)30-22(25(26,27)28)19-6-4-17(5-7-19)18-8-10-20(11-9-18)35(3,33)34/h4-11,16,21-22,30H,12-14H2,1-3H3,(H,31,32) MJJJUBXJMQFNNM-UHFFFAOYSA-N 19491 (2S)-N-(1-cyanocyclopropyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::trifluoroethylamine inhibitor, 1 Cathepsin S Homo sapiens 265 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19491&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 11283555 46519506 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34759 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) QHDGGHMKRWZOAZ-UHFFFAOYSA-N 19492 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide::CHEMBL400387::trifluoroethylamine inhibitor, 2 Cathepsin S Homo sapiens 11 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19492&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648277 46519507 CHEMBL400387 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34760 CSC[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3OS/c1-25-8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) MQRWKSMRQVMZEN-UHFFFAOYSA-N 19493 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide::trifluoroethylamine inhibitor, 3 Cathepsin S Homo sapiens 80 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19493&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648278 46519508 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34761 CS(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) WKOXXQWORKCMDZ-UHFFFAOYSA-N 19494 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide::trifluoroethylamine inhibitor, 4 Cathepsin S Homo sapiens 2173 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19494&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648279 46519509 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34762 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C22H21F4N3O3S/c1-33(31,32)12-18(20(30)29-21(13-27)10-11-21)28-19(22(24,25)26)16-4-2-14(3-5-16)15-6-8-17(23)9-7-15/h2-9,18-19,28H,10-12H2,1H3,(H,29,30) ZBNVNRCRULQVAR-UHFFFAOYSA-N 19495 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide::trifluoroethylamine inhibitor, 5 Cathepsin S Homo sapiens 10 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19495&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648280 46519510 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34763 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) HBOZUMOKFHNMQI-UHFFFAOYSA-N 19496 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 6 Cathepsin S Homo sapiens 1.8 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19496&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23626706 46519511 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34764 CS(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) RTEXRRVBLWMVBG-UHFFFAOYSA-N 19497 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 7 Cathepsin S Homo sapiens 729 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19497&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648281 46519512 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34765 CS(=O)(=O)C[C@H](N[C@@H](c1cccc(F)c1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)5-6-15)22-13(16(18,19)20)10-3-2-4-11(17)7-10/h2-4,7,12-13,22H,5-6,8H2,1H3,(H,23,24) OOVJOXGELNYKFE-UHFFFAOYSA-N 19498 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 8 Cathepsin S Homo sapiens 6.4 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19498&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648282 46519513 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34766 CS(=O)(=O)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H18F3N3O3S/c1-26(24,25)9-12(14(23)22-15(10-20)7-8-15)21-13(16(17,18)19)11-5-3-2-4-6-11/h2-6,12-13,21H,7-9H2,1H3,(H,22,23) SLQWQWLTTFJRHB-UHFFFAOYSA-N 19499 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 9 Cathepsin S Homo sapiens 2.5 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19499&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648283 46519514 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34767 CC(C)CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C19H23F4N3O3S/c1-12(2)9-30(28,29)10-15(17(27)26-18(11-24)7-8-18)25-16(19(21,22)23)13-3-5-14(20)6-4-13/h3-6,12,15-16,25H,7-10H2,1-2H3,(H,26,27) SLSHNBKPDGBYGO-UHFFFAOYSA-N 19500 (2R)-N-(1-cyanocyclopropyl)-3-[(2-methylpropane)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 10 Cathepsin S Homo sapiens 0.4 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19500&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 11857300 46519515 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34768 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C19H22F3N3O3S/c20-19(21,22)16(14-4-2-1-3-5-14)24-15(11-29(27,28)10-13-6-7-13)17(26)25-18(12-23)8-9-18/h1-5,13,15-16,24H,6-11H2,(H,25,26) QXLSWSCOFPRNEK-UHFFFAOYSA-N 19501 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 11 Cathepsin S Homo sapiens 0.6 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19501&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 11453155 46519516 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34769 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C19H21F4N3O3S/c20-14-5-3-13(4-6-14)16(19(21,22)23)25-15(10-30(28,29)9-12-1-2-12)17(27)26-18(11-24)7-8-18/h3-6,12,15-16,25H,1-2,7-10H2,(H,26,27) NOTSCKFHTQJLMM-UHFFFAOYSA-N 19502 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 12 Cathepsin S Homo sapiens 0.5 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19502&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 11351327 46519517 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34770 Fc1ccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)cc1 |r| InChI=1S/C22H21F4N3O3S/c23-17-8-6-15(7-9-17)12-33(31,32)13-18(20(30)29-21(14-27)10-11-21)28-19(22(24,25)26)16-4-2-1-3-5-16/h1-9,18-19,28H,10-13H2,(H,29,30) BLQYPJAWNZQHRK-UHFFFAOYSA-N 19503 (2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 13 Cathepsin S Homo sapiens 0.5 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19503&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648284 46519518 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34771 Fc1cccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)c1F |r| InChI=1S/C22H20F5N3O3S/c23-16-8-4-7-15(18(16)24)11-34(32,33)12-17(20(31)30-21(13-28)9-10-21)29-19(22(25,26)27)14-5-2-1-3-6-14/h1-8,17,19,29H,9-12H2,(H,30,31) LJPQZPJJLKMWAU-UHFFFAOYSA-N 19504 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 14 Cathepsin S Homo sapiens 0.3 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19504&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648285 46519519 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34772 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1cccc(F)c1F)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19F6N3O3S/c23-15-6-4-13(5-7-15)19(22(26,27)28)30-17(20(32)31-21(12-29)8-9-21)11-35(33,34)10-14-2-1-3-16(24)18(14)25/h1-7,17,19,30H,8-11H2,(H,31,32) SQIHYRIDUCIHLT-UHFFFAOYSA-N 19505 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 15 Cathepsin S Homo sapiens 0.3 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19505&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648286 46519520 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34773 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1c(Cl)cccc1Cl)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19Cl2F4N3O3S/c23-16-2-1-3-17(24)15(16)10-35(33,34)11-18(20(32)31-21(12-29)8-9-21)30-19(22(26,27)28)13-4-6-14(25)7-5-13/h1-7,18-19,30H,8-11H2,(H,31,32) KCWJNSONIBRYMQ-UHFFFAOYSA-N 19506 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,6-dichlorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 16 Cathepsin S Homo sapiens 0.7 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19506&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 11857594 46519521 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34774 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1ccccc1-c1ccccc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C28H25F4N3O3S/c29-22-12-10-20(11-13-22)25(28(30,31)32)34-24(26(36)35-27(18-33)14-15-27)17-39(37,38)16-21-8-4-5-9-23(21)19-6-2-1-3-7-19/h1-13,24-25,34H,14-17H2,(H,35,36) VUPCWWCOABEJQL-UHFFFAOYSA-N 19507 (2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 17 Cathepsin S Homo sapiens 1.8 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19507&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648287 46519522 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34775 CC(C)(c1ccc(F)cc1)S(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C24H24F5N3O3S/c1-22(2,16-5-9-18(26)10-6-16)36(34,35)13-19(21(33)32-23(14-30)11-12-23)31-20(24(27,28)29)15-3-7-17(25)8-4-15/h3-10,19-20,31H,11-13H2,1-2H3,(H,32,33) JKVDIAKIGVRXLZ-UHFFFAOYSA-N 19508 (2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 18 Cathepsin S Homo sapiens 627 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19508&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648288 46519523 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34776 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H18F5N3O3S/c22-14-3-1-13(2-4-14)18(21(24,25)26)28-17(19(30)29-20(12-27)9-10-20)11-33(31,32)16-7-5-15(23)6-8-16/h1-8,17-18,28H,9-11H2,(H,29,30) XAHPKDQGKQJQGR-UHFFFAOYSA-N 19509 (2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 19 Cathepsin S Homo sapiens 0.4 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19509&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648289 46519524 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34777 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Br)cc1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-6-8-16(9-7-15)32(30,31)12-17(19(29)28-20(13-26)10-11-20)27-18(21(23,24)25)14-4-2-1-3-5-14/h1-9,17-18,27H,10-12H2,(H,28,29) GLDNCRGNTMYXND-UHFFFAOYSA-N 19510 (2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 20 Cathepsin S Homo sapiens 0.3 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19510&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648290 46519525 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34778 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1cccc(Br)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-7-4-8-16(11-15)32(30,31)12-17(19(29)28-20(13-26)9-10-20)27-18(21(23,24)25)14-5-2-1-3-6-14/h1-8,11,17-18,27H,9-10,12H2,(H,28,29) SEBANXBXZIIACF-UHFFFAOYSA-N 19511 (2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 21 Cathepsin S Homo sapiens 0.2 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19511&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648291 46519526 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34779 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nccs1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C18H17F3N4O3S2/c19-18(20,21)14(12-4-2-1-3-5-12)24-13(15(26)25-17(11-22)6-7-17)10-30(27,28)16-23-8-9-29-16/h1-5,8-9,13-14,24H,6-7,10H2,(H,25,26) RYZCDHLOJRGBKD-UHFFFAOYSA-N 19512 (2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 22 Cathepsin S Homo sapiens 5 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19512&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648292 46519527 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34780 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nc2ccccc2s1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C22H19F3N4O3S2/c23-22(24,25)18(14-6-2-1-3-7-14)27-16(19(30)29-21(13-26)10-11-21)12-34(31,32)20-28-15-8-4-5-9-17(15)33-20/h1-9,16,18,27H,10-12H2,(H,29,30) JRUMBBNIAMXSAG-UHFFFAOYSA-N 19513 (2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 23 Cathepsin S Homo sapiens 1.3 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19513&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648293 46519528 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34781 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H18Cl2F3N3O3S/c22-15-7-6-14(10-16(15)23)33(31,32)11-17(19(30)29-20(12-27)8-9-20)28-18(21(24,25)26)13-4-2-1-3-5-13/h1-7,10,17-18,28H,8-9,11H2,(H,29,30) BXOVKTMPLLKCSP-UHFFFAOYSA-N 19514 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 24 Cathepsin S Homo sapiens 0.2 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19514&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648294 46519529 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34782 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H17Cl2F4N3O3S/c22-15-6-5-14(9-16(15)23)34(32,33)10-17(19(31)30-20(11-28)7-8-20)29-18(21(25,26)27)12-1-3-13(24)4-2-12/h1-6,9,17-18,29H,7-8,10H2,(H,30,31) HRRZJMMKIKNUDN-UHFFFAOYSA-N 19515 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 25 Cathepsin S Homo sapiens 0.2 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19515&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648295 46519530 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34783 CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@H](CCc1ccccc1)C=CS(=O)(=O)c1ccccc1 |r,w:27.29| InChI=1S/C28H37N3O5S/c1-22(2)21-26(30-28(33)31-16-18-36-19-17-31)27(32)29-24(14-13-23-9-5-3-6-10-23)15-20-37(34,35)25-11-7-4-8-12-25/h3-12,15,20,22,24,26H,13-14,16-19,21H2,1-2H3,(H,29,32)(H,30,33) YUMYYTORLYHUFW-UHFFFAOYSA-N 19516 CHEMBL222649::Morpholinurea-Leu-Hph-Vinyl-Sulfone-Phenyl::(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide::Morpholinurea-Leucine-Homophenylalaninevinyl Phenyl Sulfone::LHVS Cathepsin S Homo sapiens 1.2 6.5000 22.00 C Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5580&target=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19516&enzyme=Cathepsin+S&column=ki&startPg=0&Increment=50&submit=Search 23648296 46519531 CHEMBL222649 1 MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI 8RND,4P6E,2OP3,2HXZ,2HHN,2HH5,2H7J,2F1G,6YYR,6YYQ,6YYP,6YYO,6YYN,9GJ2,3OVX,2G7Y,2FUD,2FT2,2FRQ,2FRA,2FQ9,4P6G,3N4C,3N3G,2R9O,2R9N,2R9M,1MS6 Cathepsin S CATS_HUMAN P25774 B4DWC9 D3DV05 Q5T5I0 Q6FHS5 Q9BUG3 34784 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NCC#N |r| InChI=1S/C23H26F3N3O3S/c1-15(2)14-20(22(30)28-13-12-27)29-21(23(24,25)26)18-6-4-16(5-7-18)17-8-10-19(11-9-17)33(3,31)32/h4-11,15,20-21,29H,13-14H2,1-3H3,(H,28,30) VYFDSJLOCIGIKP-UHFFFAOYSA-N 19489 (2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfon::(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::CHEMBL437501::L-873724 Cathepsin B Homo sapiens 5239 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19489&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 9913088 46519505 CHEMBL437501 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34785 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C25H28F3N3O3S/c1-16(2)14-21(23(32)31-24(15-29)12-13-24)30-22(25(26,27)28)19-6-4-17(5-7-19)18-8-10-20(11-9-18)35(3,33)34/h4-11,16,21-22,30H,12-14H2,1-3H3,(H,31,32) MJJJUBXJMQFNNM-UHFFFAOYSA-N 19491 (2S)-N-(1-cyanocyclopropyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::trifluoroethylamine inhibitor, 1 Cathepsin B Homo sapiens 7740 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19491&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 11283555 46519506 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34786 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) QHDGGHMKRWZOAZ-UHFFFAOYSA-N 19492 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide::CHEMBL400387::trifluoroethylamine inhibitor, 2 Cathepsin B Homo sapiens 282 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19492&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648277 46519507 CHEMBL400387 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34787 CSC[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3OS/c1-25-8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) MQRWKSMRQVMZEN-UHFFFAOYSA-N 19493 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide::trifluoroethylamine inhibitor, 3 Cathepsin B Homo sapiens 417 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19493&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648278 46519508 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34788 CS(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) WKOXXQWORKCMDZ-UHFFFAOYSA-N 19494 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide::trifluoroethylamine inhibitor, 4 Cathepsin B Homo sapiens 8029 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19494&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648279 46519509 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34789 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C22H21F4N3O3S/c1-33(31,32)12-18(20(30)29-21(13-27)10-11-21)28-19(22(24,25)26)16-4-2-14(3-5-16)15-6-8-17(23)9-7-15/h2-9,18-19,28H,10-12H2,1H3,(H,29,30) ZBNVNRCRULQVAR-UHFFFAOYSA-N 19495 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide::trifluoroethylamine inhibitor, 5 Cathepsin B Homo sapiens 170 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19495&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648280 46519510 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34790 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) HBOZUMOKFHNMQI-UHFFFAOYSA-N 19496 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 6 Cathepsin B Homo sapiens 1104 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19496&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23626706 46519511 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34791 CS(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) RTEXRRVBLWMVBG-UHFFFAOYSA-N 19497 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 7 Cathepsin B Homo sapiens 9724 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19497&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648281 46519512 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34792 CS(=O)(=O)C[C@H](N[C@@H](c1cccc(F)c1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)5-6-15)22-13(16(18,19)20)10-3-2-4-11(17)7-10/h2-4,7,12-13,22H,5-6,8H2,1H3,(H,23,24) OOVJOXGELNYKFE-UHFFFAOYSA-N 19498 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 8 Cathepsin B Homo sapiens 3854 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19498&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648282 46519513 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34793 CS(=O)(=O)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H18F3N3O3S/c1-26(24,25)9-12(14(23)22-15(10-20)7-8-15)21-13(16(17,18)19)11-5-3-2-4-6-11/h2-6,12-13,21H,7-9H2,1H3,(H,22,23) SLQWQWLTTFJRHB-UHFFFAOYSA-N 19499 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 9 Cathepsin B Homo sapiens 1980 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19499&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648283 46519514 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34794 CC(C)CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C19H23F4N3O3S/c1-12(2)9-30(28,29)10-15(17(27)26-18(11-24)7-8-18)25-16(19(21,22)23)13-3-5-14(20)6-4-13/h3-6,12,15-16,25H,7-10H2,1-2H3,(H,26,27) SLSHNBKPDGBYGO-UHFFFAOYSA-N 19500 (2R)-N-(1-cyanocyclopropyl)-3-[(2-methylpropane)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 10 Cathepsin B Homo sapiens 337 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19500&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 11857300 46519515 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34795 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C19H22F3N3O3S/c20-19(21,22)16(14-4-2-1-3-5-14)24-15(11-29(27,28)10-13-6-7-13)17(26)25-18(12-23)8-9-18/h1-5,13,15-16,24H,6-11H2,(H,25,26) QXLSWSCOFPRNEK-UHFFFAOYSA-N 19501 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 11 Cathepsin B Homo sapiens 287 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19501&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 11453155 46519516 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34796 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C19H21F4N3O3S/c20-14-5-3-13(4-6-14)16(19(21,22)23)25-15(10-30(28,29)9-12-1-2-12)17(27)26-18(11-24)7-8-18/h3-6,12,15-16,25H,1-2,7-10H2,(H,26,27) NOTSCKFHTQJLMM-UHFFFAOYSA-N 19502 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 12 Cathepsin B Homo sapiens 1000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19502&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 11351327 46519517 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34797 Fc1ccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)cc1 |r| InChI=1S/C22H21F4N3O3S/c23-17-8-6-15(7-9-17)12-33(31,32)13-18(20(30)29-21(14-27)10-11-21)28-19(22(24,25)26)16-4-2-1-3-5-16/h1-9,18-19,28H,10-13H2,(H,29,30) BLQYPJAWNZQHRK-UHFFFAOYSA-N 19503 (2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 13 Cathepsin B Homo sapiens 2777 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19503&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648284 46519518 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34798 Fc1cccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)c1F |r| InChI=1S/C22H20F5N3O3S/c23-16-8-4-7-15(18(16)24)11-34(32,33)12-17(20(31)30-21(13-28)9-10-21)29-19(22(25,26)27)14-5-2-1-3-6-14/h1-8,17,19,29H,9-12H2,(H,30,31) LJPQZPJJLKMWAU-UHFFFAOYSA-N 19504 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 14 Cathepsin B Homo sapiens 1844 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19504&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648285 46519519 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34799 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1cccc(F)c1F)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19F6N3O3S/c23-15-6-4-13(5-7-15)19(22(26,27)28)30-17(20(32)31-21(12-29)8-9-21)11-35(33,34)10-14-2-1-3-16(24)18(14)25/h1-7,17,19,30H,8-11H2,(H,31,32) SQIHYRIDUCIHLT-UHFFFAOYSA-N 19505 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 15 Cathepsin B Homo sapiens 1319 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19505&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648286 46519520 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34800 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1c(Cl)cccc1Cl)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19Cl2F4N3O3S/c23-16-2-1-3-17(24)15(16)10-35(33,34)11-18(20(32)31-21(12-29)8-9-21)30-19(22(26,27)28)13-4-6-14(25)7-5-13/h1-7,18-19,30H,8-11H2,(H,31,32) KCWJNSONIBRYMQ-UHFFFAOYSA-N 19506 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,6-dichlorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 16 Cathepsin B Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19506&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 11857594 46519521 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34801 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1ccccc1-c1ccccc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C28H25F4N3O3S/c29-22-12-10-20(11-13-22)25(28(30,31)32)34-24(26(36)35-27(18-33)14-15-27)17-39(37,38)16-21-8-4-5-9-23(21)19-6-2-1-3-7-19/h1-13,24-25,34H,14-17H2,(H,35,36) VUPCWWCOABEJQL-UHFFFAOYSA-N 19507 (2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 17 Cathepsin B Homo sapiens 4041 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19507&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648287 46519522 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34802 CC(C)(c1ccc(F)cc1)S(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C24H24F5N3O3S/c1-22(2,16-5-9-18(26)10-6-16)36(34,35)13-19(21(33)32-23(14-30)11-12-23)31-20(24(27,28)29)15-3-7-17(25)8-4-15/h3-10,19-20,31H,11-13H2,1-2H3,(H,32,33) JKVDIAKIGVRXLZ-UHFFFAOYSA-N 19508 (2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 18 Cathepsin B Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19508&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648288 46519523 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34803 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H18F5N3O3S/c22-14-3-1-13(2-4-14)18(21(24,25)26)28-17(19(30)29-20(12-27)9-10-20)11-33(31,32)16-7-5-15(23)6-8-16/h1-8,17-18,28H,9-11H2,(H,29,30) XAHPKDQGKQJQGR-UHFFFAOYSA-N 19509 (2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 19 Cathepsin B Homo sapiens 7280 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19509&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648289 46519524 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34804 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Br)cc1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-6-8-16(9-7-15)32(30,31)12-17(19(29)28-20(13-26)10-11-20)27-18(21(23,24)25)14-4-2-1-3-5-14/h1-9,17-18,27H,10-12H2,(H,28,29) GLDNCRGNTMYXND-UHFFFAOYSA-N 19510 (2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 20 Cathepsin B Homo sapiens 3453 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19510&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648290 46519525 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34805 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1cccc(Br)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-7-4-8-16(11-15)32(30,31)12-17(19(29)28-20(13-26)9-10-20)27-18(21(23,24)25)14-5-2-1-3-6-14/h1-8,11,17-18,27H,9-10,12H2,(H,28,29) SEBANXBXZIIACF-UHFFFAOYSA-N 19511 (2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 21 Cathepsin B Homo sapiens 6629 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19511&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648291 46519526 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34806 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nccs1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C18H17F3N4O3S2/c19-18(20,21)14(12-4-2-1-3-5-12)24-13(15(26)25-17(11-22)6-7-17)10-30(27,28)16-23-8-9-29-16/h1-5,8-9,13-14,24H,6-7,10H2,(H,25,26) RYZCDHLOJRGBKD-UHFFFAOYSA-N 19512 (2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 22 Cathepsin B Homo sapiens 3612 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19512&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648292 46519527 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34807 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nc2ccccc2s1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C22H19F3N4O3S2/c23-22(24,25)18(14-6-2-1-3-7-14)27-16(19(30)29-21(13-26)10-11-21)12-34(31,32)20-28-15-8-4-5-9-17(15)33-20/h1-9,16,18,27H,10-12H2,(H,29,30) JRUMBBNIAMXSAG-UHFFFAOYSA-N 19513 (2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 23 Cathepsin B Homo sapiens 2971 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19513&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648293 46519528 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34808 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H18Cl2F3N3O3S/c22-15-7-6-14(10-16(15)23)33(31,32)11-17(19(30)29-20(12-27)8-9-20)28-18(21(24,25)26)13-4-2-1-3-5-13/h1-7,10,17-18,28H,8-9,11H2,(H,29,30) BXOVKTMPLLKCSP-UHFFFAOYSA-N 19514 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 24 Cathepsin B Homo sapiens 8507 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19514&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648294 46519529 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34809 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H17Cl2F4N3O3S/c22-15-6-5-14(9-16(15)23)34(32,33)10-17(19(31)30-20(11-28)7-8-20)29-18(21(25,26)27)12-1-3-13(24)4-2-12/h1-6,9,17-18,29H,7-8,10H2,(H,30,31) HRRZJMMKIKNUDN-UHFFFAOYSA-N 19515 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 25 Cathepsin B Homo sapiens 4813 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19515&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648295 46519530 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34810 CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@H](CCc1ccccc1)C=CS(=O)(=O)c1ccccc1 |r,w:27.29| InChI=1S/C28H37N3O5S/c1-22(2)21-26(30-28(33)31-16-18-36-19-17-31)27(32)29-24(14-13-23-9-5-3-6-10-23)15-20-37(34,35)25-11-7-4-8-12-25/h3-12,15,20,22,24,26H,13-14,16-19,21H2,1-2H3,(H,29,32)(H,30,33) YUMYYTORLYHUFW-UHFFFAOYSA-N 19516 CHEMBL222649::Morpholinurea-Leu-Hph-Vinyl-Sulfone-Phenyl::(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide::Morpholinurea-Leucine-Homophenylalaninevinyl Phenyl Sulfone::LHVS Cathepsin B Homo sapiens 4504 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4252&target=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19516&enzyme=Cathepsin+B&column=ki&startPg=0&Increment=50&submit=Search 23648296 46519531 CHEMBL222649 1 MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI 3PBH,2PBH,1PBH,1GMY,8HEN,8HEI,5MBM,5MBL,3AI8,8HE9,6AY2,3K9M,1QDQ,2IPP,1HUC,1CSB,1SP4 Cathepsin B CATB_HUMAN P07858 B3KQR5 B3KRR5 Q503A6 Q96D87 34811 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NCC#N |r| InChI=1S/C23H26F3N3O3S/c1-15(2)14-20(22(30)28-13-12-27)29-21(23(24,25)26)18-6-4-16(5-7-18)17-8-10-19(11-9-17)33(3,31)32/h4-11,15,20-21,29H,13-14H2,1-3H3,(H,28,30) VYFDSJLOCIGIKP-UHFFFAOYSA-N 19489 (2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfon::(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::CHEMBL437501::L-873724 Cathepsin K Oryctolagus cuniculus 0.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19489&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 9913088 46519505 CHEMBL437501 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34812 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C25H28F3N3O3S/c1-16(2)14-21(23(32)31-24(15-29)12-13-24)30-22(25(26,27)28)19-6-4-17(5-7-19)18-8-10-20(11-9-18)35(3,33)34/h4-11,16,21-22,30H,12-14H2,1-3H3,(H,31,32) MJJJUBXJMQFNNM-UHFFFAOYSA-N 19491 (2S)-N-(1-cyanocyclopropyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::trifluoroethylamine inhibitor, 1 Cathepsin K Oryctolagus cuniculus 0.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19491&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 11283555 46519506 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34813 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) QHDGGHMKRWZOAZ-UHFFFAOYSA-N 19492 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide::CHEMBL400387::trifluoroethylamine inhibitor, 2 Cathepsin K Oryctolagus cuniculus 31 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19492&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648277 46519507 CHEMBL400387 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34814 CSC[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3OS/c1-25-8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) MQRWKSMRQVMZEN-UHFFFAOYSA-N 19493 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide::trifluoroethylamine inhibitor, 3 Cathepsin K Oryctolagus cuniculus 5.0 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19493&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648278 46519508 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34815 CS(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) WKOXXQWORKCMDZ-UHFFFAOYSA-N 19494 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide::trifluoroethylamine inhibitor, 4 Cathepsin K Oryctolagus cuniculus 639 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19494&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648279 46519509 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34816 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C22H21F4N3O3S/c1-33(31,32)12-18(20(30)29-21(13-27)10-11-21)28-19(22(24,25)26)16-4-2-14(3-5-16)15-6-8-17(23)9-7-15/h2-9,18-19,28H,10-12H2,1H3,(H,29,30) ZBNVNRCRULQVAR-UHFFFAOYSA-N 19495 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide::trifluoroethylamine inhibitor, 5 Cathepsin K Oryctolagus cuniculus 5.3 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19495&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648280 46519510 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34817 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) HBOZUMOKFHNMQI-UHFFFAOYSA-N 19496 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 6 Cathepsin K Oryctolagus cuniculus 405 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19496&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23626706 46519511 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34818 CS(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) RTEXRRVBLWMVBG-UHFFFAOYSA-N 19497 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 7 Cathepsin K Oryctolagus cuniculus 1117 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19497&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648281 46519512 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34819 CS(=O)(=O)C[C@H](N[C@@H](c1cccc(F)c1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)5-6-15)22-13(16(18,19)20)10-3-2-4-11(17)7-10/h2-4,7,12-13,22H,5-6,8H2,1H3,(H,23,24) OOVJOXGELNYKFE-UHFFFAOYSA-N 19498 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 8 Cathepsin K Oryctolagus cuniculus 314 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19498&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648282 46519513 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34820 CS(=O)(=O)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H18F3N3O3S/c1-26(24,25)9-12(14(23)22-15(10-20)7-8-15)21-13(16(17,18)19)11-5-3-2-4-6-11/h2-6,12-13,21H,7-9H2,1H3,(H,22,23) SLQWQWLTTFJRHB-UHFFFAOYSA-N 19499 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 9 Cathepsin K Oryctolagus cuniculus 141 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19499&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648283 46519514 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34821 CC(C)CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C19H23F4N3O3S/c1-12(2)9-30(28,29)10-15(17(27)26-18(11-24)7-8-18)25-16(19(21,22)23)13-3-5-14(20)6-4-13/h3-6,12,15-16,25H,7-10H2,1-2H3,(H,26,27) SLSHNBKPDGBYGO-UHFFFAOYSA-N 19500 (2R)-N-(1-cyanocyclopropyl)-3-[(2-methylpropane)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 10 Cathepsin K Oryctolagus cuniculus 3058 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19500&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 11857300 46519515 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34822 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C19H22F3N3O3S/c20-19(21,22)16(14-4-2-1-3-5-14)24-15(11-29(27,28)10-13-6-7-13)17(26)25-18(12-23)8-9-18/h1-5,13,15-16,24H,6-11H2,(H,25,26) QXLSWSCOFPRNEK-UHFFFAOYSA-N 19501 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 11 Cathepsin K Oryctolagus cuniculus 555 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19501&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 11453155 46519516 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34823 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C19H21F4N3O3S/c20-14-5-3-13(4-6-14)16(19(21,22)23)25-15(10-30(28,29)9-12-1-2-12)17(27)26-18(11-24)7-8-18/h3-6,12,15-16,25H,1-2,7-10H2,(H,26,27) NOTSCKFHTQJLMM-UHFFFAOYSA-N 19502 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 12 Cathepsin K Oryctolagus cuniculus 2003 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19502&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 11351327 46519517 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34824 Fc1ccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)cc1 |r| InChI=1S/C22H21F4N3O3S/c23-17-8-6-15(7-9-17)12-33(31,32)13-18(20(30)29-21(14-27)10-11-21)28-19(22(24,25)26)16-4-2-1-3-5-16/h1-9,18-19,28H,10-13H2,(H,29,30) BLQYPJAWNZQHRK-UHFFFAOYSA-N 19503 (2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 13 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19503&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648284 46519518 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34825 Fc1cccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)c1F |r| InChI=1S/C22H20F5N3O3S/c23-16-8-4-7-15(18(16)24)11-34(32,33)12-17(20(31)30-21(13-28)9-10-21)29-19(22(25,26)27)14-5-2-1-3-6-14/h1-8,17,19,29H,9-12H2,(H,30,31) LJPQZPJJLKMWAU-UHFFFAOYSA-N 19504 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 14 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19504&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648285 46519519 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34826 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1cccc(F)c1F)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19F6N3O3S/c23-15-6-4-13(5-7-15)19(22(26,27)28)30-17(20(32)31-21(12-29)8-9-21)11-35(33,34)10-14-2-1-3-16(24)18(14)25/h1-7,17,19,30H,8-11H2,(H,31,32) SQIHYRIDUCIHLT-UHFFFAOYSA-N 19505 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 15 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19505&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648286 46519520 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34827 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1c(Cl)cccc1Cl)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19Cl2F4N3O3S/c23-16-2-1-3-17(24)15(16)10-35(33,34)11-18(20(32)31-21(12-29)8-9-21)30-19(22(26,27)28)13-4-6-14(25)7-5-13/h1-7,18-19,30H,8-11H2,(H,31,32) KCWJNSONIBRYMQ-UHFFFAOYSA-N 19506 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,6-dichlorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 16 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19506&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 11857594 46519521 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34828 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1ccccc1-c1ccccc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C28H25F4N3O3S/c29-22-12-10-20(11-13-22)25(28(30,31)32)34-24(26(36)35-27(18-33)14-15-27)17-39(37,38)16-21-8-4-5-9-23(21)19-6-2-1-3-7-19/h1-13,24-25,34H,14-17H2,(H,35,36) VUPCWWCOABEJQL-UHFFFAOYSA-N 19507 (2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 17 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19507&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648287 46519522 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34829 CC(C)(c1ccc(F)cc1)S(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C24H24F5N3O3S/c1-22(2,16-5-9-18(26)10-6-16)36(34,35)13-19(21(33)32-23(14-30)11-12-23)31-20(24(27,28)29)15-3-7-17(25)8-4-15/h3-10,19-20,31H,11-13H2,1-2H3,(H,32,33) JKVDIAKIGVRXLZ-UHFFFAOYSA-N 19508 (2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 18 Cathepsin K Oryctolagus cuniculus >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19508&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648288 46519523 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34830 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H18F5N3O3S/c22-14-3-1-13(2-4-14)18(21(24,25)26)28-17(19(30)29-20(12-27)9-10-20)11-33(31,32)16-7-5-15(23)6-8-16/h1-8,17-18,28H,9-11H2,(H,29,30) XAHPKDQGKQJQGR-UHFFFAOYSA-N 19509 (2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 19 Cathepsin K Oryctolagus cuniculus 305 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19509&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648289 46519524 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34831 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Br)cc1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-6-8-16(9-7-15)32(30,31)12-17(19(29)28-20(13-26)10-11-20)27-18(21(23,24)25)14-4-2-1-3-5-14/h1-9,17-18,27H,10-12H2,(H,28,29) GLDNCRGNTMYXND-UHFFFAOYSA-N 19510 (2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 20 Cathepsin K Oryctolagus cuniculus 290 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19510&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648290 46519525 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34832 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1cccc(Br)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-7-4-8-16(11-15)32(30,31)12-17(19(29)28-20(13-26)9-10-20)27-18(21(23,24)25)14-5-2-1-3-6-14/h1-8,11,17-18,27H,9-10,12H2,(H,28,29) SEBANXBXZIIACF-UHFFFAOYSA-N 19511 (2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 21 Cathepsin K Oryctolagus cuniculus 269 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19511&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648291 46519526 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34833 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nccs1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C18H17F3N4O3S2/c19-18(20,21)14(12-4-2-1-3-5-12)24-13(15(26)25-17(11-22)6-7-17)10-30(27,28)16-23-8-9-29-16/h1-5,8-9,13-14,24H,6-7,10H2,(H,25,26) RYZCDHLOJRGBKD-UHFFFAOYSA-N 19512 (2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 22 Cathepsin K Oryctolagus cuniculus 376 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19512&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648292 46519527 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34834 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nc2ccccc2s1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C22H19F3N4O3S2/c23-22(24,25)18(14-6-2-1-3-7-14)27-16(19(30)29-21(13-26)10-11-21)12-34(31,32)20-28-15-8-4-5-9-17(15)33-20/h1-9,16,18,27H,10-12H2,(H,29,30) JRUMBBNIAMXSAG-UHFFFAOYSA-N 19513 (2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 23 Cathepsin K Oryctolagus cuniculus 825 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19513&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648293 46519528 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34835 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H18Cl2F3N3O3S/c22-15-7-6-14(10-16(15)23)33(31,32)11-17(19(30)29-20(12-27)8-9-20)28-18(21(24,25)26)13-4-2-1-3-5-13/h1-7,10,17-18,28H,8-9,11H2,(H,29,30) BXOVKTMPLLKCSP-UHFFFAOYSA-N 19514 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 24 Cathepsin K Oryctolagus cuniculus 314 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19514&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648294 46519529 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34836 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H17Cl2F4N3O3S/c22-15-6-5-14(9-16(15)23)34(32,33)10-17(19(31)30-20(11-28)7-8-20)29-18(21(25,26)27)12-1-3-13(24)4-2-12/h1-6,9,17-18,29H,7-8,10H2,(H,30,31) HRRZJMMKIKNUDN-UHFFFAOYSA-N 19515 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 25 Cathepsin K Oryctolagus cuniculus 691 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19515&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648295 46519530 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34837 CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@H](CCc1ccccc1)C=CS(=O)(=O)c1ccccc1 |r,w:27.29| InChI=1S/C28H37N3O5S/c1-22(2)21-26(30-28(33)31-16-18-36-19-17-31)27(32)29-24(14-13-23-9-5-3-6-10-23)15-20-37(34,35)25-11-7-4-8-12-25/h3-12,15,20,22,24,26H,13-14,16-19,21H2,1-2H3,(H,29,32)(H,30,33) YUMYYTORLYHUFW-UHFFFAOYSA-N 19516 CHEMBL222649::Morpholinurea-Leu-Hph-Vinyl-Sulfone-Phenyl::(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide::Morpholinurea-Leucine-Homophenylalaninevinyl Phenyl Sulfone::LHVS Cathepsin K Oryctolagus cuniculus 6.2 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2032&target=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19516&enzyme=Cathepsin+K&column=ki&startPg=0&Increment=50&submit=Search 23648296 46519531 CHEMBL222649 1 MWGLKVLLLPVVSFALHPEEILDTQWELWKKTYSKQYNSKVDEISRRLIWEKNLKHISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPPSRSHSNDTLYIPDWEGRTPDSIDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENYGCGGGYMTNAFQYVQRNRGIDSEDAYPYVGQDESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDENCSSDNVNHAVLAVGYGIQKGNKHWIIKNSWGESWGNKGYILMARNKNNACGIANLASFPKM 5JH3,5JA7,5J94,5T6U Cathepsin K CATK_RABIT P43236 34838 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NCC#N |r| InChI=1S/C23H26F3N3O3S/c1-15(2)14-20(22(30)28-13-12-27)29-21(23(24,25)26)18-6-4-16(5-7-18)17-8-10-19(11-9-17)33(3,31)32/h4-11,15,20-21,29H,13-14H2,1-3H3,(H,28,30) VYFDSJLOCIGIKP-UHFFFAOYSA-N 19489 (2S)-N-(cyanomethyl)-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfon::(2S)-N-(cyanomethyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::CHEMBL437501::L-873724 Procathepsin L Homo sapiens 264 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19489&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 9913088 46519505 CHEMBL437501 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34839 CC(C)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C25H28F3N3O3S/c1-16(2)14-21(23(32)31-24(15-29)12-13-24)30-22(25(26,27)28)19-6-4-17(5-7-19)18-8-10-20(11-9-18)35(3,33)34/h4-11,16,21-22,30H,12-14H2,1-3H3,(H,31,32) MJJJUBXJMQFNNM-UHFFFAOYSA-N 19491 (2S)-N-(1-cyanocyclopropyl)-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-methanesulfonylphenyl)phenyl]ethyl]amino}pentanamide::trifluoroethylamine inhibitor, 1 Procathepsin L Homo sapiens 456 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19491&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 11283555 46519506 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34840 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) QHDGGHMKRWZOAZ-UHFFFAOYSA-N 19492 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfonylpropanamide::CHEMBL400387::trifluoroethylamine inhibitor, 2 Procathepsin L Homo sapiens 427 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19492&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648277 46519507 CHEMBL400387 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34841 CSC[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3OS/c1-25-8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) MQRWKSMRQVMZEN-UHFFFAOYSA-N 19493 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-(methylsulfanyl)propanamide::trifluoroethylamine inhibitor, 3 Procathepsin L Homo sapiens 456 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19493&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648278 46519508 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34842 CS(=O)C[C@H](N[C@@H](c1ccc(Br)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17BrF3N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) WKOXXQWORKCMDZ-UHFFFAOYSA-N 19494 (2R)-2-{[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]amino}-N-(1-cyanocyclopropyl)-3-methanesulfinylpropanamide::trifluoroethylamine inhibitor, 4 Procathepsin L Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19494&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648279 46519509 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34843 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(cc1)-c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C22H21F4N3O3S/c1-33(31,32)12-18(20(30)29-21(13-27)10-11-21)28-19(22(24,25)26)16-4-2-14(3-5-16)15-6-8-17(23)9-7-15/h2-9,18-19,28H,10-12H2,1H3,(H,29,30) ZBNVNRCRULQVAR-UHFFFAOYSA-N 19495 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-[4-(4-fluorophenyl)phenyl]ethyl]amino}propanamide::trifluoroethylamine inhibitor, 5 Procathepsin L Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19495&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648280 46519510 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34844 CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) HBOZUMOKFHNMQI-UHFFFAOYSA-N 19496 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 6 Procathepsin L Homo sapiens 1013 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19496&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23626706 46519511 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34845 CS(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O2S/c1-26(25)8-12(14(24)23-15(9-21)6-7-15)22-13(16(18,19)20)10-2-4-11(17)5-3-10/h2-5,12-13,22H,6-8H2,1H3,(H,23,24) RTEXRRVBLWMVBG-UHFFFAOYSA-N 19497 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfinyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 7 Procathepsin L Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19497&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648281 46519512 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34846 CS(=O)(=O)C[C@H](N[C@@H](c1cccc(F)c1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H17F4N3O3S/c1-27(25,26)8-12(14(24)23-15(9-21)5-6-15)22-13(16(18,19)20)10-3-2-4-11(17)7-10/h2-4,7,12-13,22H,5-6,8H2,1H3,(H,23,24) OOVJOXGELNYKFE-UHFFFAOYSA-N 19498 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(3-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 8 Procathepsin L Homo sapiens 911 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19498&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648282 46519513 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34847 CS(=O)(=O)C[C@H](N[C@@H](c1ccccc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C16H18F3N3O3S/c1-26(24,25)9-12(14(23)22-15(10-20)7-8-15)21-13(16(17,18)19)11-5-3-2-4-6-11/h2-6,12-13,21H,7-9H2,1H3,(H,22,23) SLQWQWLTTFJRHB-UHFFFAOYSA-N 19499 (2R)-N-(1-cyanocyclopropyl)-3-methanesulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 9 Procathepsin L Homo sapiens 1035 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19499&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648283 46519514 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34848 CC(C)CS(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C19H23F4N3O3S/c1-12(2)9-30(28,29)10-15(17(27)26-18(11-24)7-8-18)25-16(19(21,22)23)13-3-5-14(20)6-4-13/h3-6,12,15-16,25H,7-10H2,1-2H3,(H,26,27) SLSHNBKPDGBYGO-UHFFFAOYSA-N 19500 (2R)-N-(1-cyanocyclopropyl)-3-[(2-methylpropane)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 10 Procathepsin L Homo sapiens 132 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19500&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 11857300 46519515 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34849 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C19H22F3N3O3S/c20-19(21,22)16(14-4-2-1-3-5-14)24-15(11-29(27,28)10-13-6-7-13)17(26)25-18(12-23)8-9-18/h1-5,13,15-16,24H,6-11H2,(H,25,26) QXLSWSCOFPRNEK-UHFFFAOYSA-N 19501 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 11 Procathepsin L Homo sapiens 68 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19501&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 11453155 46519516 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34850 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)CC1CC1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C19H21F4N3O3S/c20-14-5-3-13(4-6-14)16(19(21,22)23)25-15(10-30(28,29)9-12-1-2-12)17(27)26-18(11-24)7-8-18/h3-6,12,15-16,25H,1-2,7-10H2,(H,26,27) NOTSCKFHTQJLMM-UHFFFAOYSA-N 19502 (2R)-N-(1-cyanocyclopropyl)-3-(cyclopropylmethane)sulfonyl-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 12 Procathepsin L Homo sapiens 188 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19502&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 11351327 46519517 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34851 Fc1ccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)cc1 |r| InChI=1S/C22H21F4N3O3S/c23-17-8-6-15(7-9-17)12-33(31,32)13-18(20(30)29-21(14-27)10-11-21)28-19(22(24,25)26)16-4-2-1-3-5-16/h1-9,18-19,28H,10-13H2,(H,29,30) BLQYPJAWNZQHRK-UHFFFAOYSA-N 19503 (2R)-N-(1-cyanocyclopropyl)-3-{[(4-fluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 13 Procathepsin L Homo sapiens 86 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19503&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648284 46519518 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34852 Fc1cccc(CS(=O)(=O)C[C@H](N[C@@H](c2ccccc2)C(F)(F)F)C(=O)NC2(CC2)C#N)c1F |r| InChI=1S/C22H20F5N3O3S/c23-16-8-4-7-15(18(16)24)11-34(32,33)12-17(20(31)30-21(13-28)9-10-21)29-19(22(25,26)27)14-5-2-1-3-6-14/h1-8,17,19,29H,9-12H2,(H,30,31) LJPQZPJJLKMWAU-UHFFFAOYSA-N 19504 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 14 Procathepsin L Homo sapiens 105 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19504&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648285 46519519 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34853 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1cccc(F)c1F)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19F6N3O3S/c23-15-6-4-13(5-7-15)19(22(26,27)28)30-17(20(32)31-21(12-29)8-9-21)11-35(33,34)10-14-2-1-3-16(24)18(14)25/h1-7,17,19,30H,8-11H2,(H,31,32) SQIHYRIDUCIHLT-UHFFFAOYSA-N 19505 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,3-difluorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 15 Procathepsin L Homo sapiens 121 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19505&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648286 46519520 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34854 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1c(Cl)cccc1Cl)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C22H19Cl2F4N3O3S/c23-16-2-1-3-17(24)15(16)10-35(33,34)11-18(20(32)31-21(12-29)8-9-21)30-19(22(26,27)28)13-4-6-14(25)7-5-13/h1-7,18-19,30H,8-11H2,(H,31,32) KCWJNSONIBRYMQ-UHFFFAOYSA-N 19506 (2R)-N-(1-cyanocyclopropyl)-3-{[(2,6-dichlorophenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 16 Procathepsin L Homo sapiens 249 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19506&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 11857594 46519521 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34855 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)Cc1ccccc1-c1ccccc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C28H25F4N3O3S/c29-22-12-10-20(11-13-22)25(28(30,31)32)34-24(26(36)35-27(18-33)14-15-27)17-39(37,38)16-21-8-4-5-9-23(21)19-6-2-1-3-7-19/h1-13,24-25,34H,14-17H2,(H,35,36) VUPCWWCOABEJQL-UHFFFAOYSA-N 19507 (2R)-N-(1-cyanocyclopropyl)-3-{[(2-phenylphenyl)methane]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 17 Procathepsin L Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19507&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648287 46519522 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34856 CC(C)(c1ccc(F)cc1)S(=O)(=O)C[C@H](N[C@@H](c1ccc(F)cc1)C(F)(F)F)C(=O)NC1(CC1)C#N |r| InChI=1S/C24H24F5N3O3S/c1-22(2,16-5-9-18(26)10-6-16)36(34,35)13-19(21(33)32-23(14-30)11-12-23)31-20(24(27,28)29)15-3-7-17(25)8-4-15/h3-10,19-20,31H,11-13H2,1-2H3,(H,32,33) JKVDIAKIGVRXLZ-UHFFFAOYSA-N 19508 (2R)-N-(1-cyanocyclopropyl)-3-{[2-(4-fluorophenyl)propane-2-]sulfonyl}-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 18 Procathepsin L Homo sapiens >10000 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19508&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648288 46519523 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34857 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(F)cc1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H18F5N3O3S/c22-14-3-1-13(2-4-14)18(21(24,25)26)28-17(19(30)29-20(12-27)9-10-20)11-33(31,32)16-7-5-15(23)6-8-16/h1-8,17-18,28H,9-11H2,(H,29,30) XAHPKDQGKQJQGR-UHFFFAOYSA-N 19509 (2R)-N-(1-cyanocyclopropyl)-3-[(4-fluorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 19 Procathepsin L Homo sapiens 22 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19509&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648289 46519524 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34858 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Br)cc1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-6-8-16(9-7-15)32(30,31)12-17(19(29)28-20(13-26)10-11-20)27-18(21(23,24)25)14-4-2-1-3-5-14/h1-9,17-18,27H,10-12H2,(H,28,29) GLDNCRGNTMYXND-UHFFFAOYSA-N 19510 (2R)-3-[(4-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 20 Procathepsin L Homo sapiens 15 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19510&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648290 46519525 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34859 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1cccc(Br)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H19BrF3N3O3S/c22-15-7-4-8-16(11-15)32(30,31)12-17(19(29)28-20(13-26)9-10-20)27-18(21(23,24)25)14-5-2-1-3-6-14/h1-8,11,17-18,27H,9-10,12H2,(H,28,29) SEBANXBXZIIACF-UHFFFAOYSA-N 19511 (2R)-3-[(3-bromobenzene)sulfonyl]-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 21 Procathepsin L Homo sapiens 23 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19511&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648291 46519526 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34860 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nccs1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C18H17F3N4O3S2/c19-18(20,21)14(12-4-2-1-3-5-12)24-13(15(26)25-17(11-22)6-7-17)10-30(27,28)16-23-8-9-29-16/h1-5,8-9,13-14,24H,6-7,10H2,(H,25,26) RYZCDHLOJRGBKD-UHFFFAOYSA-N 19512 (2R)-N-(1-cyanocyclopropyl)-3-(1,3-thiazole-2-sulfonyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 22 Procathepsin L Homo sapiens 181 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19512&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648292 46519527 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34861 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1nc2ccccc2s1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C22H19F3N4O3S2/c23-22(24,25)18(14-6-2-1-3-7-14)27-16(19(30)29-21(13-26)10-11-21)12-34(31,32)20-28-15-8-4-5-9-17(15)33-20/h1-9,16,18,27H,10-12H2,(H,29,30) JRUMBBNIAMXSAG-UHFFFAOYSA-N 19513 (2R)-3-(1,3-benzothiazole-2-sulfonyl)-N-(1-cyanocyclopropyl)-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 23 Procathepsin L Homo sapiens 114 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19513&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648293 46519528 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34862 FC(F)(F)[C@@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)c1ccccc1 |r| InChI=1S/C21H18Cl2F3N3O3S/c22-15-7-6-14(10-16(15)23)33(31,32)11-17(19(30)29-20(12-27)8-9-20)28-18(21(24,25)26)13-4-2-1-3-5-13/h1-7,10,17-18,28H,8-9,11H2,(H,29,30) BXOVKTMPLLKCSP-UHFFFAOYSA-N 19514 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-phenylethyl]amino}propanamide::trifluoroethylamine inhibitor, 24 Procathepsin L Homo sapiens 24 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19514&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648294 46519529 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34863 Fc1ccc(cc1)[C@H](N[C@@H](CS(=O)(=O)c1ccc(Cl)c(Cl)c1)C(=O)NC1(CC1)C#N)C(F)(F)F |r| InChI=1S/C21H17Cl2F4N3O3S/c22-15-6-5-14(9-16(15)23)34(32,33)10-17(19(31)30-20(11-28)7-8-20)29-18(21(25,26)27)12-1-3-13(24)4-2-12/h1-6,9,17-18,29H,7-8,10H2,(H,30,31) HRRZJMMKIKNUDN-UHFFFAOYSA-N 19515 (2R)-N-(1-cyanocyclopropyl)-3-[(3,4-dichlorobenzene)sulfonyl]-2-{[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino}propanamide::trifluoroethylamine inhibitor, 25 Procathepsin L Homo sapiens 41 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19515&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648295 46519530 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0 34864 CC(C)C[C@@H](NC(=O)N1CCOCC1)C(=O)N[C@H](CCc1ccccc1)C=CS(=O)(=O)c1ccccc1 |r,w:27.29| InChI=1S/C28H37N3O5S/c1-22(2)21-26(30-28(33)31-16-18-36-19-17-31)27(32)29-24(14-13-23-9-5-3-6-10-23)15-20-37(34,35)25-11-7-4-8-12-25/h3-12,15,20,22,24,26H,13-14,16-19,21H2,1-2H3,(H,29,32)(H,30,33) YUMYYTORLYHUFW-UHFFFAOYSA-N 19516 CHEMBL222649::Morpholinurea-Leu-Hph-Vinyl-Sulfone-Phenyl::(2S)-N-[(3S,5E)-6-(benzenesulfonyl)-4-oxo-1-phenylhex-5-en-3-yl]-4-methyl-2-(morpholin-4-ylcarbonylamino)pentanamide::Morpholinurea-Leucine-Homophenylalaninevinyl Phenyl Sulfone::LHVS Procathepsin L Homo sapiens 5.7 Curated from the literature by BindingDB 10.1016/j.bmcl.2007.06.023 10.7270/Q26W98C3 17590332 aid1797859 Gauthier, JY; Black, WC; Courchesne, I; Cromlish, W; Desmarais, S; Houle, R; Lamontagne, S; Li, CS; Massé, F; McKay, DJ; Ouellet, M; Robichaud, J; Truchon, JF; Truong, VL; Wang, Q; Percival, MD 9/1/2007 12/18/2007 Merck Frosst Centre For Therapeutic Research http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2012&target=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=19516&enzyme=Procathepsin+L&column=ki&startPg=0&Increment=50&submit=Search 23648296 46519531 CHEMBL222649 1 MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV 8GX2,7W34,7W33,3OF9,3OF8,8UAC,8HFV,8HET,6F06,6EZX,6EZP,5MQY,5MAJ,5MAE,5F02,4AXM,4AXL,3H8C,3H8B,3H89,3BC3,2YJC,2YJB,2YJ9,2YJ8,2YJ2,2XU5,2XU4,2XU3,1MHW,1ICF,5I4H Procathepsin L CATL1_HUMAN P07711 Q6IAV1 Q96QJ0